During the past decade, Centre Hépato-Biliaire - Hôpital Paul Brousse conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hépato-Biliaire - Hôpital Paul Brousse" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 4 trials, followed by "Rennes University Hospital" with 4 trials sponsored, "Grifols Therapeutics LLC" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hépato-Biliaire - Hôpital Paul Brousse" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "ECHOPEN" with 2 trials as a collaborator, "EIT Health" with 2 trials as a collaborator, "Instituto Grifols, S.A." with 2 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hépato-Biliaire - Hôpital Paul Brousse" are "Hepatitis C" (3 trials), "Evidence of Liver Transplantation" (2 trials), "Abdominal Effusion" (1 trials), "Acute-On-Chronic Liver Failure" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Centre Hépato-Biliaire - Hôpital Paul Brousse" in a lesser frequency.

Most popular intervention types in "Centre Hépato-Biliaire - Hôpital Paul Brousse" are "Drug" (6 trials), "Procedure" (5 trials), "Device" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "EchOpen ultra-portable ultrasound device" (2 trials), "Placebo" (2 trials), "Standard ultrasound examination by an independent referent radiologist" (2 trials), "Albutein 20% Injectable Solution" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hépato-Biliaire - Hôpital Paul Brousse" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hépato-Biliaire - Hôpital Paul Brousse". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centre Hépato-Biliaire - Hôpital Paul Brousse, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hépato-Biliaire - Hôpital Paul Brousse, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".